Literature DB >> 14978805

The antimicrobial peptide LL-37 binds to the human plasma protein apolipoprotein A-I.

Yuqin Wang, Jan Johansson, Birgitta Agerberth, Hans Jörnvall, William J Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14978805     DOI： 10.1002/rcm.1361

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN： 0951-4198            Impact factor:   2.419


× No keyword cloud information.
  10 in total

1.  Cathelicidin LL-37 peptide regulates endothelial cell stiffness and endothelial barrier permeability.

Authors:  Fitzroy J Byfield; Qi Wen; Katarzyna Leszczynska; Alina Kulakowska; Zbigniew Namiot; Paul A Janmey; Robert Bucki
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-13       Impact factor: 4.249

2.  Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.

Authors:  Y Elaine Lau; Dawn M E Bowdish; Celine Cosseau; Robert E W Hancock; Donald J Davidson
Journal:  Am J Respir Cell Mol Biol       Date:  2005-12-09       Impact factor: 6.914

3.  Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.

Authors:  Eszter Ostorhazi; Ferenc Rozgonyi; Andras Sztodola; Ferenc Harmos; Ilona Kovalszky; Dora Szabo; Daniel Knappe; Ralf Hoffmann; Marco Cassone; John D Wade; Robert A Bonomo; Laszlo Otvos
Journal:  J Antimicrob Chemother       Date:  2010-09-01       Impact factor: 5.790

4.  Carbamylated LL-37 as a modulator of the immune response.

Authors:  Catalin Koro; Annelie Hellvard; Nicolas Delaleu; Veronika Binder; Carsten Scavenius; Brith Bergum; Izabela Główczyk; Helen M Roberts; Iain L C Chapple; Melissa M Grant; Maria Rapala-Kozik; Kinga Klaga; Jan J Enghild; Jan Potempa; Piotr Mydel
Journal:  Innate Immun       Date:  2016-02-15       Impact factor: 2.680

5.  The ratio of serum LL-37 levels to blood leucocyte count correlates with COVID-19 severity.

Authors:  Matthias Keutmann; Gabriele Hermes; Denise Meinberger; Annika Roth; Jannik Stemler; Oliver A Cornely; Andreas R Klatt; Thomas Streichert
Journal:  Sci Rep       Date:  2022-06-08       Impact factor: 4.996

6.  Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.

Authors:  Michal Gutner; Stella Chaushu; Daniela Balter; Gilad Bachrach
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

7.  Short and Robust Anti-Infective Lipopeptides Engineered Based on the Minimal Antimicrobial Peptide KR12 of Human LL-37.

Authors:  Jayaram Lakshmaiah Narayana; Radha Golla; Biswajit Mishra; Xiuqing Wang; Tamara Lushnikova; Yingxia Zhang; Atul Verma; Vikas Kumar; Jingwei Xie; Guangshun Wang
Journal:  ACS Infect Dis       Date:  2021-04-23       Impact factor: 5.578

8.  Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity.

Authors:  Tamer Kahraman; Gozde Gucluler; Ismail Simsek; Fuat Cem Yagci; Muzaffer Yildirim; Can Ozen; Ayhan Dinc; Mayda Gursel; Lolai Ikromzoda; Tolga Sutlu; Stephen Gay; Ihsan Gursel
Journal:  J Extracell Vesicles       Date:  2017-02-28

9.  Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide.

Authors:  Judith Wendler; Bjoern O Schroeder; Dirk Ehmann; Louis Koeninger; Daniela Mailänder-Sánchez; Christina Lemberg; Stephanie Wanner; Martin Schaller; Eduard F Stange; Nisar P Malek; Christopher Weidenmaier; Salomé LeibundGut-Landmann; Jan Wehkamp
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

10.  The lipid components of high-density lipoproteins (HDL) are essential for the binding and transportation of antimicrobial peptides in human serum.

Authors:  Wen-Hung Tang; Shi-Han Wang; Chiu-Feng Wang; Yun Mou; Min-Guan Lin; Chwan-Deng Hsiao; You-Di Liao
Journal:  Sci Rep       Date:  2022-02-16       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.